✦ LIBER ✦

The lymphoma-like polychemotherapy regimen “Dexa-BEAM” in advanced and extramedullary multiple myeloma

✍ Scribed by Rasche, Leo; Strifler, Susanne; Duell, Johannes; Rosenwald, Andreas; Buck, Andreas; Maeder, Uwe; Einsele, Hermann; Knop, Stefan

Book ID: 121552161
Publisher: Springer
Year: 2014
Tongue: English
Weight: 522 KB
Volume: 93
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-014-2023-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effectiveness and Cost Effectiveness

The Effectiveness and Cost Effectiveness of Plerixafor + GCSF Versus GCSF ± Chemotherapy as Salvage Mobilization Regimens in Lymphoma and Multiple Myeloma Patients

✍ H.W. Tuffaha; A.A. Hussein; S. Sharma; H. Abu-Jazar; O.S. Al-Rawi; A.M. Saad; A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The efficacy and safety of bortezomib an

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

✍ Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

Effect of the Cytochrome P450 2C19 Inhib

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin’s Lymphoma or Multiple Myeloma

✍ Dr David I. Quinn, John Nemunaitis, Jyotsna Fuloria, Carolyn D. Britten, Nashat 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 191 KB

379 A first in human phase I study of th

379 A first in human phase I study of the proteasome inhibitor CEP-18770 in patients (pts) with advanced solid tumors, non-Hodgkin's lymphomas (NHL) and multiple myeloma (MM)

✍ C. Sessa; G. Martinelli; D. Hess; A. Delmonte; C. Noberasco; S. Sammassimo; E. G 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Treatment with Plerixafor in non-Hodgkin

Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient

✍ Patrick Stiff; Ivana Micallef; Philip McCarthy; Margarida Magalhaes-Silverman; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 273 KB